أستراليا - الإنجليزية - APVMA (Australian Pesticides and Veterinary Medicines Authority)

wobelea pty ltd t/a poolkare chemicals - bromochlorodimethylhydantoin - algicide

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

leadiant biosciences, inc. - pegademase bovine (unii: hw3h7d91f6) (pegademase bovine - unii:hw3h7d91f6) - pegademase bovine 250 [iu] in 1 ml - adagen® (pegademase bovine) injection is indicated for enzyme replacement therapy for adenosine deaminase (ada) deficiency in patients with severe combined immunodeficiency disease (scid) who are not suitable candidates for – or who have failed – bone marrow transplantation. adagen® (pegademase bovine) injection is recommended for use in infants from birth or in children of any age at the time of diagnosis. adagen® (pegademase bovine) injection is not intended as a replacement for hla identical bone marrow transplant therapy. adagen® (pegademase bovine) injection is also not intended to replace continued close medical supervision and the initiation of appropriate diagnostic tests and therapy (e.g., antibiotics, nutrition, oxygen, gammaglobulin) as indicated for intercurrent illnesses. there is no evidence to support the safety and efficacy of adagen® (pegademase bovine) injection as preparatory or support therapy for bone marrow transplantation. since adagen® (pegademase bovine) injection is admin

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

baxter healthcare corporation - human immunoglobulin g (unii: 66y330cjhs) (human immunoglobulin g - unii:66y330cjhs) - human immunoglobulin g 50 mg in 1 ml

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

baxalta us inc. - human immunoglobulin g (unii: 66y330cjhs) (human immunoglobulin g - unii:66y330cjhs) - human immunoglobulin g 50 ug in 1 ml

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

baxalta us inc. - human immunoglobulin g (unii: 66y330cjhs) (human immunoglobulin g - unii:66y330cjhs) - human immunoglobulin g 50 mg in 1 ml - primary immunodeficiency (pi) gammagard s/d is indicated for the treatment of primary immunodeficiency (pi) associated with defects in humoral immunity, in adults and children two years and older. this includes, but is not limited to, congenital agammaglobulinemia, common variable immunodeficiency, wiskott-aldrich syndrome, and severe combined immunodeficiencies.1,2,3 b-cell chronic lymphocytic leukemia (cll) gammagard s/d is indicated for prevention of bacterial infections in patients with hypogammaglobulinemia and/or recurrent bacterial infections associated with b-cell chronic lymphocytic leukemia (cll).4 idiopathic thrombocytopenic purpura (itp) gammagard s/d is indicated for the treatment of adult chronic idiopathic thrombocytopenic purpura to increase platelet count and to prevent and/or to control bleeding. kawasaki syndrome gammagard s/d is indicated for the prevention of coronary artery aneurysms associated with kawasaki syndrome in pediatric patients.5 - gammagard s/d is contraindicated in patients

كندا - الإنجليزية - Health Canada

grifols therapeutics llc - immunoglobulin (human) - solution - 10g - immunoglobulin (human) 10g - serums

كندا - الإنجليزية - Health Canada

grifols therapeutics llc - immunoglobulin (human) - solution - 10g - immunoglobulin (human) 10g - serums

الولايات المتحدة - الإنجليزية - NLM (National Library of Medicine)

baxalta us inc. - human immunoglobulin g (unii: 66y330cjhs) (human immunoglobulin g - unii:66y330cjhs) - human immunoglobulin g 50 ug in 1 ml